Genetic Engineering News: Breaking Genetic Engineering News, Comments and Articles.

23:39 EDT 25th October 2014 | BioPortfolio

Genetic Engineering NewsRSS

Read the latest Genetic Engineering News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Genetic Engineering.

Search or Follow Our Genetic Engineering News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Genetic Engineering News.

Showing "genetic engineering genetics" News Articles 1 to 25 of 7,500+

Saturday 25th October 2014

Detecting Ebola with a Piece of Paper | MIT Technology Review

Innovation can save lives:Could complex genetic experiments one day be as simple to carry out as an over-the-counter pregnancy test?That’s the idea behind new research from James Collins, a synthetic biologist at Boston University, who says he’s been able to print the ingredients for simple DNA experiments on paper, freeze-dry them, and use them as much as a year later.The work, described this...

Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets

Adipic Acid Market report focuses the global market on the basis of applications (Polyurethane, Adipic Esters, Polyamide 66 & Others), end-user industries, and geography. The adipic acid market, along with its end use in polyamide 66, polyurethane, and adipic esters witnessed a significant growth in the past few years. (http://www.marketsandmarkets.com/Market-Reports/adipic-acid-269.html) (PRW...

Researchers Developing Patch That Can Collect Health-Related Data From Sweat

Chuck Bednar for redOrbit.com - Your Universe Online Experts from the University of Cincinnati and the US Air Force Research Laboratory at Wright-Patterson Air Force Base in Ohio are joining forces to develop a lightweight, wearable device that can analyze sweat using a smartphone in order to perform a variety of health-related diagnostic tests. The new gadge

Friday 24th October 2014

Dicerna to Announce Third-Quarter 2014 Financial Results and Host Conference Call on November 6, 2014

Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced that the Company will release its third-quarter 2014 financial results before market open on Thursday, November 6, 2014. Management will conduct a conference call at 8:30 a.m. (EST) that day, to discuss the Company's financial resu...

Knowing Genetic Risk for Cancer May Not Change Behavior

FRIDAY, Oct. 24, 2014 -- As more genetic tests are developed that spot increased risks for certain cancers, one might think that high-risk people would be more proactive about getting screened. But a new study suggests that, at least with colon...

RTI International Metals Schedules 2014 Third Quarter Financial Results Conference Call and Webcast

RTI International Metals, Inc. (NYSE: RTI) today announced that it will host a conference call and live webcast on Wednesday, November 5, 2014, at 10:00 a.m. Eastern Time, to review the Company’s third quarter 2014 financial results, which will be released before the market opens that morning. Conference Call Information To parti...

Engineering Nano-Sized Microfibers for Tissue Engineering and Biosensors

New material advances tissue engineering and drug deliveryRead more about Engineering Nano-Sized Microfibers for Tissue Engineering and BiosensorsComments

P!nk And Friends Performed At "2014 The Power of Pink" House of Blues In Hollywood On October 23, 2014

SANTA MONICA, Calif., Oct. 24, 2014 /PRNewswire/ -- Saint John's Health Center (SJHC) hosted its 2014 Power of Pink event October 23, at House of Blues in West Hollywood to benefit the Cancer Prevention Program at Saint John's Health Center. The evening was attended by more than 700 people. P!nk performed an intimate acoustic set with friends including  Linda Perry, Nate Ruess, Dallas Gr...

Unlike FDA panel, CHMP backs AZ's olaparib

EMA's CHMP recommended marketing authorization of Lynparza olaparib from AstraZeneca plc (LSE:AZN; NYSE:AZN) as maintenance treatment of platinum-sensitive relapsed ovarian, fallopian tube or peritoneal cancer in patients with germline breast cancer ...

Genetics Underpin Bullying Victimisation Influence on Paranoi

(News-Medical) – Bullying victimisation in childhood may indicate genetic risk for later psychosis, rather than being an environmental trigger, say UK researchers. The team’s study of 4826 twin pairs revealed that bullying victimisation was m...

Stratasys Included in New TV Series "Titan American Built"

Show airs on MAVTV Oct. 24 at 10 p.m. ET Stratasys Ltd. (Nasdaq:SSYS), a global leader of 3D printing and additive manufacturing solutions and GoEngineer, a Stratasys reseller, will be part of a new television series on

Scenesse recommended for rare disease by EMA/CHMP

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorization under exceptional circumstances for Scenesse (afamelanotide) for the prevention of phototoxicity in adults with...

Patients help Clinuvel win CHMP recommendation for orphan Scenesse

The CHMP has recommended the drug for the prevention of phototoxicity in adults with erythropoietic protoporphyria (EPP), a rare genetic disease affecting just 10,000 people across Europe, which causes intolerance to light. Patients suffering from EP...

Local robotics teams compete - a "FIRST" at next week's MD&M Minneapolis- October 29-30th at the Minneapolis Convention Center

SANTA MONICA, Calif., Oct. 24, 2014 /PRNewswire/ -- America's future engineers will connect with world-renown medtech leaders over friendly robotic competition at the Medical Design and Manufacturing (MD&M) Minneapolis Exposition and Conference on October 29-30th at the Minneapolis Convention Center. The event will highlight local student built robots from the "For Inspiration and Re...

Academy and GRAMMY Award-winner Jamie Foxx and his sister DeOndra Dixon Help Launch Down Syndrome World™ during Down Syndrome Awareness Month

Global Down Syndrome Foundation Magazine Covers Groundbreaking Research, Medical Care, and Features about People with Down Syndrome The Global Down Syndrome Foundation is pleased to announce the launch of Down Syndrome World, the first national magazine dedicated to covering important topics affecting people with Down syndrome, their families, f...

Myriad Establishes New Tumor Research Lab in Europe

Myriad Genetics Inc. announced it has established a Tumor BRACAnalysis CDx laboratory in Europe. Myriad's next-generation Tumor BRACAnalysis CDx test is a companion diagnostic that will identify up to 50% more patients with BRAC mutations who may benefit from treatment with PARP inhibitors, such as olaparib, compared to conventional germline testing alone.Read more about Myriad Establishes New Tum...

Myriad Genetics, Inc.: Myriad Establishes Tumor BRACAnalysis CDx Laboratory in Europe

Tumor BRACAnalysis CDx Will Identify More Patients for Treatment With PARP Inhibitors SALT LAKE CITY and ZURICH, 2014-10-24 15:17 CEST (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today ...

The Peculiar Internet Market for Genetic Health Reports

MIT Technology Review | Since the FDA made clear last November that it would not tolerate companies selling genetic tests linked to health reports without regulatory approval, a workaround for customers of companies like 23andMe has emerged online. &...

The Association for Molecular Pathology Adds Late-Breaking Session on Laboratory Developed Procedures Oversight and Regulation to the 2014 Annual Meeting Program

Press Conference to Follow Late-Breaking Session The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals announced that it has added a late-breaking session addressing laboratory developed procedures (LDPs) oversight and regulation to its 2014 Annual Meeting program (www.amp.org...

Europe Approves Novel Australian Drug Developed for Rare Sun Disease

The first new pharmaceutical drug invented and developed for an untreated disorder by any Australian company has received regulatory approval from the European Medicines Agency (EMA). SCENESSE® (afamelanotide 16mg) treats the debilitating genetic disorder porphyria (EPP), or absolute intolerance to sunlight. The fear of lifelong burns requires EPP patient...

EU backs drug for rare sun intolerance from Australia's Clinuvel

LONDON, Oct 24 (Reuters) - European patients with a rare genetic disease that causes intolerance to sunlight should soon have a new treatment option, following a green light for a drug from Australia's Clinuvel Pharmaceuticals.

MIT researchers develop new way to model effects of cancer-causing genetic mutations

Sequencing the genomes of tumor cells has revealed thousands of genetic mutations linked with cancer. However, sifting through this deluge of information to figure out which of these mutations actually drive cancer growth has proven to be a tedious, ...

Breaking the nano barrier

Researchers at the New York Univ. Polytechnic School of Engineering have broken new ground in the development of proteins that form specialized fibers used in medicine and nanotechnology. For as long as scientists have been able to create new protein...

DuPont Pioneer, Perdue AgriBusiness Announce Plans to Double Acreage for the 2015 Plenish® High Oleic Soybean Program

Demand for Healthier Soybean Oil Grows Des Moines, Iowa (PRWEB) October 24, 2014 DuPont Pioneer and Perdue AgriBusiness announced today that Perdue plans to more than double the acreage contracted for Plenish® high oleic soybeans in 2015 in geographies supplying its soybean crush facility in Salisbury, Md. The high oleic soybean oil produced from this program will target several markets incl...

More Women Preserving Fertility with Egg Freezing

In response to a growing number of younger women seeking to freeze their eggs, Olive Fertility Centre has created an information video on new egg freezing technology. Vancouver, Canada (PRWEB) October 24, 2014 A recent study in the medical journal Lancet (4 October 2014) recommends that all women in their 20's or 30's should have the chance to freeze their egg in case they want a child la...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks